{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T22:43:51Z","timestamp":1781995431701,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00108-025-01858-9","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T02:42:28Z","timestamp":1739846548000},"page":"258-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AVK\u00a0II: Femoropopliteale L\u00e4sionen","Peripheral artery disease II: femoropopliteal lesions"],"prefix":"10.1007","volume":"66","author":[{"given":"Christos","family":"Rammos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tienush","family":"Rassaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Korosoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"6","key":"1858_CR1","first-page":"366","volume":"52","author":"S Betge","year":"2023","unstructured":"Betge\u00a0S, Engelbertz\u00a0C, Espinola-Klein\u00a0C et\u00a0al (2023) Analysis of endovascular therapy for peripheral arterial disease in all German hospitals. Vasa 52(6):366\u2013378","journal-title":"Vasa"},{"issue":"4","key":"1858_CR2","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s00270-014-0904-3","volume":"37","author":"F Fanelli","year":"2014","unstructured":"Fanelli\u00a0F, Cannavale\u00a0A, Gazzetti\u00a0M et\u00a0al (2014) Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol 37(4):898\u2013907","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1858_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X241231943","author":"C Schofthaler","year":"2024","unstructured":"Schofthaler\u00a0C, Troisi\u00a0N, Torsello\u00a0G et\u00a0al (2024) Safety and effectiveness of the phoenix atherectomy device for endovascular treatment of common femoral and popliteal arteries: Results of the EN-MOBILE trial. Vasc Med. https:\/\/doi.org\/10.1177\/1358863X241231943","journal-title":"Vasc Med"},{"issue":"6","key":"1858_CR4","first-page":"386","volume":"52","author":"AM Muller","year":"2023","unstructured":"Muller\u00a0AM, Lohn-Kannengiesser\u00a0L, Bradaric\u00a0C et\u00a0al (2023) Outcomes of endovascular treatment for popliteal artery disease. Vasa 52(6):386\u2013393","journal-title":"Vasa"},{"key":"1858_CR5","unstructured":"Korosoglou G, Schmidt A, Lichtenberg M et\u00a0al (2025) Global Algorithm for the Endovascular Treatment of Chronic Femoropopliteal Lesions: An Interdisciplinary Expert Opinion Statement. JACC Cardiovasc Interv (In press)"},{"key":"1858_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/00033197241263381","author":"G Korosoglou","year":"2024","unstructured":"Korosoglou\u00a0G, Feld\u00a0J, Langhoff\u00a0R et\u00a0al (2024) Safety and Effectiveness of Debulking for the Treatment of Infrainguinal Peripheral Artery Disease. Data From the Recording Courses of vascular Diseases Registry in 2910 Patients. Angiology. https:\/\/doi.org\/10.1177\/00033197241263381","journal-title":"Angiology"},{"issue":"2","key":"1858_CR7","first-page":"205","volume":"60","author":"M Lichtenberg","year":"2019","unstructured":"Lichtenberg\u00a0M, Korosoglou\u00a0G (2019) Atherectomy plus antirestenotic therapy for SFA lesions: evolving evidence for better patency rates in complex lesions. J\u00a0Cardiovasc Surg (torino) 60(2):205\u2013211","journal-title":"J Cardiovasc Surg (torino)"},{"issue":"6","key":"1858_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1024\/0301-1526\/a001150","volume":"53","author":"G Korosoglou","year":"2024","unstructured":"Korosoglou\u00a0G, Rammos\u00a0C, Blessing\u00a0E (2024) Crossing by or effective BYCROSSing in long & calcified peripheral lesions with a\u00a0New Kid on the Block? Vasa 53(6):363\u2013365","journal-title":"Vasa"},{"issue":"6","key":"1858_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1024\/0301-1526\/a001151","volume":"53","author":"D Liebetrau","year":"2024","unstructured":"Liebetrau\u00a0D, Tessarek\u00a0J, Elger\u00a0F, Peters\u00a0V, Scheurig-Munkler\u00a0C, Hyhlik-Durr\u00a0A (2024) Technical aspects of the new BYCROSS(TM) atherectomy device\u2014preliminary results after 28\u00a0patients. Vasa 53(6):388\u2013396","journal-title":"Vasa"},{"issue":"5","key":"1858_CR10","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.4244\/EIJ-D-21-01070","volume":"18","author":"S Giusca","year":"2022","unstructured":"Giusca\u00a0S, Hagstotz\u00a0S, Lichtenberg\u00a0M et\u00a0al (2022) Phoenix atherectomy for patients with peripheral artery disease. EuroIntervention 18(5):e432\u2013e42","journal-title":"EuroIntervention"},{"issue":"9","key":"1858_CR11","doi-asserted-by":"publisher","first-page":"e004848","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848","volume":"10","author":"T Zeller","year":"2017","unstructured":"Zeller\u00a0T, Langhoff\u00a0R, Rocha-Singh\u00a0KJ et\u00a0al (2017) Directional Atherectomy Followed by a\u00a0Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study. Circ Cardiovasc Interv 10(9):e4848","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"1858_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/ccd.30339","volume":"100","author":"A Babaev","year":"2022","unstructured":"Babaev\u00a0A, Halista\u00a0M, Bakirova\u00a0Z, Avtushka\u00a0V, Matsumura\u00a0M, Maehara\u00a0A (2022) Directional versus orbital atherectomy of femoropopliteal artery lesions: Angiographic and intravascular ultrasound outcomes. Catheter Cardiovasc Interv 100(4):687\u2013695","journal-title":"Catheter Cardiovasc Interv"},{"issue":"8","key":"1858_CR13","first-page":"355","volume":"26","author":"R Dattilo","year":"2014","unstructured":"Dattilo\u00a0R, Himmelstein\u00a0SI, Cuff RF. The COMPLIANCE 360 degrees Trial (2014) a\u00a0randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J\u00a0Invasive Cardiol 26(8):355\u2013360","journal-title":"J Invasive Cardiol"},{"key":"1858_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/15266028231161246","author":"D Dukic","year":"2023","unstructured":"Dukic\u00a0D, Martin\u00a0K, Lichtenberg\u00a0M et\u00a0al (2023) Novel Therapeutic Concepts for Complex Femoropopliteal Lesions Using the Jetstream Atherectomy System. J\u00a0Endovasc Ther. https:\/\/doi.org\/10.1177\/15266028231161246","journal-title":"J Endovasc Ther"},{"issue":"6","key":"1858_CR15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ejvs.2022.10.014","volume":"64","author":"M Andrassy","year":"2022","unstructured":"Andrassy\u00a0M, Lichtenberg\u00a0M, Brodmann\u00a0M, Andrassy\u00a0J, Giusca\u00a0S, Korosoglou\u00a0G (2022) Jetstream Rotational Atherectomy and Drug Coated Balloon Angioplasty with In Stent Re-stenosis and Occlusions. A\u00a0Two Centre Study. Eur J Vasc Endovasc Surg 64(6):733\u2013734","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"8","key":"1858_CR16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jcin.2014.05.006","volume":"7","author":"JF McKinsey","year":"2014","unstructured":"McKinsey\u00a0JF, Zeller\u00a0T, Rocha-Singh\u00a0KJ, Jaff\u00a0MR, Garcia\u00a0LA, Investigators DL. Lower extremity revascularization using directional atherectomy (2014) 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv 7(8):923\u2013933","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"1858_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/ccd.29777","volume":"98","author":"KJ Rocha-Singh","year":"2021","unstructured":"Rocha-Singh\u00a0KJ, Sachar\u00a0R, DeRubertis\u00a0BG et\u00a0al (2021) Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study. Catheter Cardiovasc Interv 98(3):549\u2013558","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"1858_CR18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/1526602820935611","volume":"27","author":"S Giannopoulos","year":"2020","unstructured":"Giannopoulos\u00a0S, Secemsky\u00a0EA, Mustapha\u00a0JA et\u00a0al (2020) Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia. J\u00a0Endovasc Ther 27(5):714\u2013725","journal-title":"J Endovasc Ther"},{"issue":"3","key":"1858_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0003319716646682","volume":"68","author":"B Freitas","year":"2017","unstructured":"Freitas\u00a0B, Steiner\u00a0S, Bausback\u00a0Y et\u00a0al (2017) Rotarex Mechanical Debulking in Acute and Subacute Arterial Lesions. Angiology 68(3):233\u2013241","journal-title":"Angiology"},{"issue":"6","key":"1858_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1024\/0301-1526\/a001034","volume":"51","author":"C Rammos","year":"2022","unstructured":"Rammos\u00a0C, Manzke\u00a0A, Lortz\u00a0J et\u00a0al (2022) Mechanical atherothrombectomy improves endothelial function through plaque burden reduction in PAD. Vasa 51(6):377\u2013385","journal-title":"Vasa"},{"issue":"9","key":"1858_CR21","first-page":"CD006680","volume":"9","author":"BG Wardle","year":"2020","unstructured":"Wardle\u00a0BG, Ambler\u00a0GK, Radwan\u00a0RW, Hinchliffe\u00a0RJ, Twine\u00a0CP (2020) Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev 9(9):CD6680","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1858_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ccd.27635","volume":"92","author":"DN Feldman","year":"2018","unstructured":"Feldman\u00a0DN, Armstrong\u00a0EJ, Aronow\u00a0HD et\u00a0al (2018) SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Catheter Cardiovasc Interv 92(1):124\u2013140","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"1858_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/1526602820914598","volume":"27","author":"G Adams","year":"2020","unstructured":"Adams\u00a0G, Shammas\u00a0N, Mangalmurti\u00a0S et\u00a0al (2020) Intravascular Lithotripsy for Treatment of Calcified Lower Extremity Arterial Stenosis: Initial Analysis of the Disrupt PAD III Study. J\u00a0Endovasc Ther 27(3):473\u2013480","journal-title":"J Endovasc Ther"},{"issue":"4","key":"1858_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1024\/0301-1526\/a001133","volume":"53","author":"M Sagris","year":"2024","unstructured":"Sagris\u00a0M, Ktenopoulos\u00a0N, Soulaidopoulos\u00a0S et\u00a0al (2024) Intravascular lithotripsy in peripheral lesions with severe calcification and its use in TAVI procedure\u2014a\u00a0meta-analysis. Vasa 53(4):263\u2013274","journal-title":"Vasa"},{"issue":"4","key":"1858_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1024\/0301-1526\/a001125","volume":"53","author":"H Scheidhauer","year":"2024","unstructured":"Scheidhauer\u00a0H, Moebius-Winkler\u00a0S, Aftanski\u00a0P, Schulze\u00a0PC, Kretzschmar\u00a0D (2024) Analysis of interventional treatment options of the common femoral artery\u2014a\u00a0retrospective single center experience. Vasa 53(4):227\u2013236","journal-title":"Vasa"},{"issue":"2","key":"1858_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ccd.27943","volume":"93","author":"M Brodmann","year":"2019","unstructured":"Brodmann\u00a0M, Werner\u00a0M, Holden\u00a0A et\u00a0al (2019) Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD II. Catheter Cardiovasc Interv 93(2):335\u2013342","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"1858_CR27","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/ccd.28729","volume":"95","author":"MV Madhavan","year":"2020","unstructured":"Madhavan\u00a0MV, Shahim\u00a0B, Mena-Hurtado\u00a0C, Garcia\u00a0L, Crowley\u00a0A, Parikh\u00a0SA (2020) Efficacy and safety of intravascular lithotripsy for the treatment of peripheral arterial disease: An individual patient-level pooled data analysis. Catheter Cardiovasc Interv 95(5):959\u2013968","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"1858_CR28","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","volume":"14","author":"G Tepe","year":"2021","unstructured":"Tepe\u00a0G, Brodmann\u00a0M, Werner\u00a0M et\u00a0al (2021) Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial. JACC Cardiovasc Interv 14(12):1352\u20131361","journal-title":"JACC Cardiovasc Interv"},{"key":"1858_CR29","doi-asserted-by":"crossref","unstructured":"Tepe G (2022) Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial. J\u00a0Soc Cardiovasc Angiogr Interv 1(4)","DOI":"10.1016\/j.jscai.2022.100341"},{"issue":"3","key":"1858_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jvs.2019.01.080","volume":"70","author":"C Caradu","year":"2019","unstructured":"Caradu\u00a0C, Lakhlifi\u00a0E, Colacchio\u00a0EC et\u00a0al (2019) Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. J\u00a0Vasc Surg 70(3):981\u2013995 (e10)","journal-title":"J Vasc Surg"},{"issue":"24","key":"1858_CR31","doi-asserted-by":"publisher","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","volume":"7","author":"K Katsanos","year":"2018","unstructured":"Katsanos\u00a0K, Spiliopoulos\u00a0S, Kitrou\u00a0P, Krokidis\u00a0M, Karnabatidis\u00a0D (2018) Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A\u00a0Systematic Review and Meta-Analysis of Randomized Controlled Trials. J\u00a0Am Heart Assoc 7(24):e11245","journal-title":"J Am Heart Assoc"},{"issue":"38","key":"1858_CR32","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1093\/eurheartj\/ehz698","volume":"41","author":"E Freisinger","year":"2020","unstructured":"Freisinger\u00a0E, Koeppe\u00a0J, Gerss\u00a0J et\u00a0al (2020) Mortality after use of paclitaxel-based devices in peripheral arteries: a\u00a0real-world safety analysis. Eur Heart\u00a0J 41(38):3732\u20133739","journal-title":"Eur Heart J"},{"issue":"1","key":"1858_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1186\/s13063-021-05631-9","volume":"22","author":"U Teichgraber","year":"2021","unstructured":"Teichgraber\u00a0U, Ingwersen\u00a0M, Platzer\u00a0S et\u00a0al (2021) Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial. Trials 22(1):665","journal-title":"Trials"},{"issue":"6","key":"1858_CR34","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jvs.2016.05.073","volume":"64","author":"K Stavroulakis","year":"2016","unstructured":"Stavroulakis\u00a0K, Torsello\u00a0G, Manal\u00a0A et\u00a0al (2016) Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7\u00a0years. J\u00a0Vasc Surg 64(6):1696\u20131702","journal-title":"J Vasc Surg"},{"key":"1858_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/CIRCINTERVENTIONS.113.000937","volume":"8","author":"L Garcia","year":"2015","unstructured":"Garcia\u00a0L, Jaff\u00a0MR, Metzger\u00a0C et\u00a0al (2015) Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial. Circ Cardiovasc Interv 8:5","journal-title":"Circ Cardiovasc Interv"},{"issue":"21","key":"1858_CR36","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.122.059606","volume":"146","author":"Y Goueffic","year":"2022","unstructured":"Goueffic\u00a0Y, Torsello\u00a0G, Zeller\u00a0T et\u00a0al (2022) Efficacy of a\u00a0Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial. Circulation 146(21):1564\u20131576","journal-title":"Circulation"},{"issue":"3","key":"1858_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","volume":"44","author":"S Muller-Hulsbeck","year":"2021","unstructured":"Muller-Hulsbeck\u00a0S, Benko\u00a0A, Soga\u00a0Y et\u00a0al (2021) Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent. Cardiovasc Intervent Radiol 44(3):368\u2013375","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1858_CR38","unstructured":"ANGIOLOGIE DGF. S3-Leitlinie zur Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit AWMF Online 2024."},{"issue":"6","key":"1858_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","volume":"73","author":"Y Bausback","year":"2019","unstructured":"Bausback\u00a0Y, Wittig\u00a0T, Schmidt\u00a0A et\u00a0al (2019) Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease. J\u00a0Am Coll Cardiol 73(6):667\u2013679","journal-title":"J Am Coll Cardiol"},{"key":"1858_CR40","unstructured":"Tepe G. SPORTS Trial. TCT October 24 (2023) San Francisco. CA (2023; abstract)"},{"issue":"1","key":"1858_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00270-014-1024-9","volume":"38","author":"J Lammer","year":"2015","unstructured":"Lammer\u00a0J, Zeller\u00a0T, Hausegger\u00a0KA et\u00a0al (2015) Sustained benefit at 2\u00a0years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial. Cardiovasc Intervent Radiol 38(1):25\u201332","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"1858_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jacc.2011.09.036","volume":"59","author":"A Tosaka","year":"2012","unstructured":"Tosaka\u00a0A, Soga\u00a0Y, Iida\u00a0O et\u00a0al (2012) Classification and clinical impact of restenosis after femoropopliteal stenting. J\u00a0Am Coll Cardiol 59(1):16\u201323","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1858_CR43","doi-asserted-by":"publisher","first-page":"e007055","DOI":"10.1161\/CIRCINTERVENTIONS.118.007055","volume":"11","author":"S Cassese","year":"2018","unstructured":"Cassese\u00a0S, Wolf\u00a0F, Ingwersen\u00a0M et\u00a0al (2018) Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis. Circ Cardiovasc Interv 11(12):e7055","journal-title":"Circ Cardiovasc Interv"},{"key":"1858_CR44","doi-asserted-by":"crossref","unstructured":"Korosoglou G, Torsello G, Saratzis A et\u00a0al (2023) ENdovascular Versus SUrgical Treatment for All-comer Patients With PROsthetic Bypass Graft Occlusion: The Multicentre ENSUPRO Study. Eur J Vasc Endovasc Surg","DOI":"10.1016\/j.jvs.2024.04.006"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01858-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01858-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01858-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:24:50Z","timestamp":1741184690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01858-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1858"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01858-9","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"29 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Rammos: Honoraria received from: Avinger, Biotronik, BD Bard, Cordis, Daichii-Sankyo, Inari, Novartis, Shockwave, Veryan. Consulted for: BD Bard, Boston Scientific Corp., Veryan, Shockwave. Institutional Grants for research, clinical trial, or drug studies received from: Avinger, Biotronik, Boston Scientific Corp., Veryan, Med Alliance. G.\u00a0Korosoglou: received speaker honoraria from Philips, Cordis, Boston scientific and BARD Peripheral Vascular Inc., and institutional grants from Philips and Bard Peripheral Vascular Inc. T.\u00a0Rassaf: No conflicts of interest to declare with this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}